Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
Sponsor: Novo Nordisk A/S
Summary
The purpose of this study is to collect data on adverse events from third party registries that include information about adverse events from patients with haemophilia B treated with nonacog beta pegol. The third party registries include PedNet Haemophilia Registry (PedNet) and the European Haemophilia Safety Surveillance System (EUHASS). Data from national and international registries in countries where nonacog beta pegol has been approved and marketed could be included in the data collection.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2018-10-01
Completion Date
2027-10-01
Last Updated
2025-06-02
Healthy Volunteers
No
Conditions
Interventions
Nonacog beta pegol
Treatment with commercially available nonacog beta pegol according to routine clinical practice at the discretion of the treating physician.
Locations (2)
PedNet Haemophilia Registry
Baarn, Netherlands
European Haemophilia Safety Surveillance Registry
Sheffield, United Kingdom